ORCID as entered in ROS

Select Publications
2023, 'Comparing treatment utilisation and predictors among smokers with and without mental health disorders: Implications for equity in smoking cessation efforts', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S171 - S172
,2018, 'CESSATION AND RELAPSE PREVENTION TRIAL: VAPORISED NICOTINE PRODUCTS FOR PEOPLE ON OPIATE SUBSTITUTION THERAPY, OR WHO ARE LIVING WITH HEPATITIS C OR HIV', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S6 - S6, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Cytisine is an effective smoking cessation medication: more evidence now than ever before', in Tobacco, Smoking Control and Health Education, European Respiratory Society, pp. PA4482 - PA4482, presented at ERS International Congress 2017 abstracts, http://dx.doi.org/10.1183/1393003.congress-2017.pa4482
,2016, 'A PILOT CLUSTER RANDOMISED TRIAL OF ELECTRONIC FEEDBACK, ONLINE AND TELEPHONE SUPPORT ON MULTIPLE HEALTH BEHAVIOURS AMONG VOCATIONAL EDUCATION STUDENTS', in INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, SPRINGER, pp. S73 - S73, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000388943400233&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,